These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 580534)

  • 21. Regulation of plasma PAI-1 concentrations in HAART-associated lipodystrophy during rosiglitazone therapy.
    Yki-Järvinen H; Sutinen J; Silveira A; Korsheninnikova E; Fisher RM; Kannisto K; Ehrenborg E; Eriksson P; Hamsten A
    Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):688-94. PubMed ID: 12615670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative and qualitative differences in subcutaneous adipose tissue stores across lipodystrophy types shown by magnetic resonance imaging.
    Al-Attar SA; Pollex RL; Robinson JF; Miskie BA; Walcarius R; Little CH; Rutt BK; Hegele RA
    BMC Med Imaging; 2007 Mar; 7():3. PubMed ID: 17352814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic studies and autonomic function in children with partial lipodystrophy.
    West RJ; Fosbrooke AS; Lloyd JK
    Arch Dis Child; 1974 Aug; 49(8):627-32. PubMed ID: 4418207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic consequences of lipodystrophy in mouse models.
    Reue K; Phan J
    Curr Opin Clin Nutr Metab Care; 2006 Jul; 9(4):436-41. PubMed ID: 16778573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dysfunction of lipid metabolism in lipodystrophic Seipin-deficient mice.
    Wang M; Gao M; Liao J; Han Y; Wang Y; Liu G
    Biochem Biophys Res Commun; 2015 May; 461(2):206-10. PubMed ID: 25866184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Congenital lipodystrophies and dyslipidemias.
    Prieur X; Le May C; Magré J; Cariou B
    Curr Atheroscler Rep; 2014 Sep; 16(9):437. PubMed ID: 25047893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adipose-specific knockout of SEIPIN/BSCL2 results in progressive lipodystrophy.
    Liu L; Jiang Q; Wang X; Zhang Y; Lin RC; Lam SM; Shui G; Zhou L; Li P; Wang Y; Cui X; Gao M; Zhang L; Lv Y; Xu G; Liu G; Zhao D; Yang H
    Diabetes; 2014 Jul; 63(7):2320-31. PubMed ID: 24622797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies in congenital generalized lipodystrophy. VI. Suppressible and non-suppressible insulin-like activities of plasma.
    Søvik O; Oseid S
    Acta Endocrinol (Copenh); 1975 Aug; 79(4):720-8. PubMed ID: 1174276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Congenital generalized lipodystrophy. Lipid changes. Therapeutic trials].
    Lestradet C; Massol J; Plouvier E; Narboni G; Raffi A
    Arch Fr Pediatr; 1985 Oct; 42(8):705-7. PubMed ID: 4074100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intramyocellular lipid accumulation and reduced whole body lipid oxidation in HIV lipodystrophy.
    Luzi L; Perseghin G; Tambussi G; Meneghini E; Scifo P; Pagliato E; Del Maschio A; Testolin G; Lazzarin A
    Am J Physiol Endocrinol Metab; 2003 Feb; 284(2):E274-80. PubMed ID: 12388139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipodystrophy.
    Helm TN; Bisker E; Bergfeld WF
    Cutis; 2001 Feb; 67(2):163-4. PubMed ID: 11236228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophy.
    Gan SK; Samaras K; Thompson CH; Kraegen EW; Carr A; Cooper DA; Chisholm DJ
    Diabetes; 2002 Nov; 51(11):3163-9. PubMed ID: 12401706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Metabolism of adipose tissue in normal humans and in various metabolic disorders. II. The adipose tissue in metabolic diseases].
    Sezille G; Jaillard J; Biserte G
    Ann Biol Clin (Paris); 1970; 28(3):209-15. PubMed ID: 5478256
    [No Abstract]   [Full Text] [Related]  

  • 34. Increased intramyocellular lipid accumulation in HIV-infected women with fat redistribution.
    Torriani M; Thomas BJ; Barlow RB; Librizzi J; Dolan S; Grinspoon S
    J Appl Physiol (1985); 2006 Feb; 100(2):609-14. PubMed ID: 16223978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathology of congenital generalized lipodystrophy in Agpat2-/- mice.
    Vogel P; Read R; Hansen G; Wingert J; Dacosta CM; Buhring LM; Shadoan M
    Vet Pathol; 2011 May; 48(3):642-54. PubMed ID: 21051554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A case of congenital total lipodystrophy--metabolic and post-mortem examination (author's transl)].
    Togawa K; Naito C; Terayama I; Iimura Y; Ogata E
    Nihon Naika Gakkai Zasshi; 1974 Feb; 63(2):153-62. PubMed ID: 4471726
    [No Abstract]   [Full Text] [Related]  

  • 37. Visceral white adipose tissue is susceptible to alcohol-induced lipodystrophy in rats: role of acetaldehyde.
    Zhang W; Zhong W; Sun X; Sun Q; Tan X; Li Q; Sun X; Zhou Z
    Alcohol Clin Exp Res; 2015 Mar; 39(3):416-23. PubMed ID: 25703837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seipin deficiency alters fatty acid Delta9 desaturation and lipid droplet formation in Berardinelli-Seip congenital lipodystrophy.
    Boutet E; El Mourabit H; Prot M; Nemani M; Khallouf E; Colard O; Maurice M; Durand-Schneider AM; Chrétien Y; Grès S; Wolf C; Saulnier-Blache JS; Capeau J; Magré J
    Biochimie; 2009 Jun; 91(6):796-803. PubMed ID: 19278620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generalized lipodystrophy, congenital and acquired (lipoatrophy).
    Seip M; Trygstad O
    Acta Paediatr Suppl; 1996 Jun; 413():2-28. PubMed ID: 8783769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased incorporation of glucose into lipids and increased lactate production by adipose tissue after long-term treatment of rats with D-fenfluramine.
    al-Sieni AI; Plested CP; Rolland Y; Brindley DN
    Biochem Pharmacol; 1989 Nov; 38(21):3661-7. PubMed ID: 2557024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.